Is 2027 the year we kick fentanyl for good?

For years, America’s overdose crisis seemed to move in only one direction. More fentanyl. More grieving families. More communities struggling to imagine when the devastation might end.

Now, something hopeful is happening: Deaths are falling substantially, and the improvement has continued long enough to suggest a meaningful change.

Could 2027 be the year America finally kicks its fentanyl habit? That is an ambitious expectation. But asking the question no longer seems foolish.

Finalized federal figures show drug overdose deaths falling from approximately 108,000 in 2022 to 79,000 in 2024. Provisional estimates put the 2025 toll near 70,000. These figures cover all drug overdoses, with declining fentanyl-related deaths accounting for much of the improvement.

It’s incredible.

President Donald Trump has good reason to welcome continued progress during his administration. His opportunity now is to help make this reversal permanent.

Understanding what changed will be essential.

One promising explanation involves the drug supply itself. 

The Drug Enforcement Administration has reported declining fentanyl purity, while researchers have examined evidence of a disruption in the illicit fentanyl market. Difficulties obtaining precursor chemicals may be contributing, although the precise causes remain disputed.

Americans have repeatedly heard that fighting the supply is futile because traffickers will always find another route. Yet evidence that supply disruptions may reduce deaths gives Washington reason to keep pressing manufacturers and the networks delivering their products.

For Trump, international pressure over fentanyl has a plausible public health purpose. The task is to establish which actions produce results and maintain them long enough to weaken the business.

Enforcement alone, however, cannot resolve addiction among people already dependent on opioids.

Naloxone can reverse an opioid overdose and give someone another chance. That chance becomes far more valuable when it leads to effective treatment and sustained recovery. An emergency reversal can keep a family from planning a funeral; it cannot guarantee that the next emergency will never come.

Researchers remain divided over how much expanded naloxone access explains the national downturn. Some argue that fewer overdose emergencies point to changes beyond more successful rescues. That uncertainty should encourage better investigation while preserving a lifesaving intervention.

Treatment requires similar scrutiny. Making care easier to provide does not automatically mean more people receive it. Research examining the elimination of a federal buprenorphine prescribing restriction found more prescribers but little change in patient numbers during the first year studied.

The practical question is whether someone struggling with addiction can enter treatment and remain engaged when motivation fades or circumstances deteriorate.

There is another reason for optimism: younger Americans.

NIH-supported surveys show that use of most drugs among teenagers remained low in 2025. Separately, the overdose death rate among people ages 15–24 fell 37 percent in 2024. Neither finding guarantees future progress, but both suggest that another generation need not experience the same devastation.

Preventing addiction before it begins could make today’s improvement much more durable. Credible warnings about counterfeit pills, combined with early intervention, have an opening worth pursuing.

Still, lower deaths do not mean the danger has passed. The DEA warns that increasingly complicated drug mixtures remain hazardous despite declining average fentanyl purity. A national improvement offers no reassurance about the contents of an individual pill.

America may never eliminate illicit fentanyl entirely. But we can aspire to make addiction less common and recovery more attainable.

Success in 2027 would mean another substantial decline in deaths, accompanied by evidence that fewer people are entering addiction and more are leaving it behind.

For families watching someone struggle, even that would be an extraordinary change. For communities exhausted by years of loss, it would offer something more concrete than reassurance.

Trump has an opportunity to help deliver it. The country has finally gained ground against fentanyl. The challenge now is to hold that ground and keep moving forward.

(Contributing writer, Brooke Bell)